Table 1.
Five most significantly affected canonical pathways by miR-328 knockdown predicted using IPA (Ingenuity Pathway Analysis software, Ingenuity Systems, www.ingenuity.com). A) Pooled proteomics setup. B) Separated proteomics setup.
| Proteomics setup | Top canonical pathways | p-value |
|---|---|---|
| A) Pooled | ||
| Soluble fraction | eIF2 Signaling | 1.33E−48 |
| Regulation of eIF4 and p70S6K Signaling | 1.16E−32 | |
| Mitochondrial Dysfunction | 3.19E−28 | |
| Protein Ubiquitination Pathway | 2.46E−27 | |
| mTOR Signaling | 2.31E−23 | |
| Microsomal fraction | eIF2 Signaling | 1.33E−48 |
| Regulation of eIF4 and p70S6K Signaling | 1.16E−32 | |
| Mitochondrial Dysfunction | 3.19E−28 | |
| Protein Ubiquitination Pathway | 2.46E−27 | |
| mTOR Signaling | 2.31E−23 | |
| B) Separated | ||
| Soluble fraction | eIF2 Signaling | 9.79E−56 |
| Regulation of eIF4 and p70S6K Signaling | 1.90E−35 | |
| Protein Ubiquitination Pathway | 5.23E−26 | |
| Mitochondrial Dysfunction | 1.49E−23 | |
| mTOR Signaling | 1.40E−20 | |
| Microsomal fraction | eIF2 Signaling | 9.79E−56 |
| Regulation of eIF4 and p70S6K Signaling | 2.12E−36 | |
| Mitochondrial Dysfunction | 1.84E−35 | |
| Protein Ubiquitination Pathway | 1.72E−30 | |
| mTOR Signaling | 4.53E−26 |